Medical Blog About Treatment Abroad
Welcome to our medical blog – it is dedicated to empowering patients with knowledge about global healthcare! We created this platform with the intention to bridge the gap between patients and the medical innovations available globally.
What's Inside: Discover new and rare methods in oncology, immunology, heart surgery, neurosurgery, and other medical fields! Our health travel insights show how medical journeys open new possibilities with advanced treatments unavailable locally, including specialized cancer care abroad.
Who Benefits: This resource is for patients and their families who seek new treatment methods and explore options at leading international hospitals. Those who want to make informed healthcare decisions beyond borders.
Why Read: Booking Health experts provide verified information through patient-friendly articles – they translate complex medical advances into accessible info. Stay current with the latest developments in global healthcare and discover how international medicine can transform treatment outcomes!
Browse our latest articles and take the first step toward better health outcomes!
Treatment - page 6
Treatment of stage 4 breast cancer in Germany
Breast cancer (BCa) affects more than 2 million women each year, and approximately 10 percent of the cases are diagnosed with stage 4 and metastases. German hospitals are the best providers of cancer treatment, as the most effective ones due to the combination of innovative technology with holistic treatment of the patient.
Treatment of soft tissue sarcoma with dendritic cells
Soft tissue sarcomas are rare malignant tumors that develop in muscles, fat, cartilage, blood vessels, and other non-epithelial tissues throughout the body. With approximately 13,520 new cases expected in the United States in 2025, these cancers represent less than 1% of all cancer diagnoses. While advanced sarcomas differ...
Revolutionary Immunotherapy Treatments for Prostate Cancer in Germany
Prostate cancer immunotherapy represents a breakthrough in cancer treatment that's showing remarkable results across various disease stages. Immunotherapy works where other treatments have failed and can no longer stop cancer progression. While traditionally considered for advanced cases, recent clinical evidence demonstrates...
Treatment of stage 4 pancreatic cancer in Germany
Pancreatic cancer (ICD C25) is one of the most common gastrointestinal cancers. More than 300,000 new cases are diagnosed in the world every year. This tumor accounts for 3% of all cancers, which is a fairly high figure. The treatment methods offered in Germany allow for achieving excellent results, even at stage 4 of the pathology.
Dendritic Cell Therapy for Lung Cancer Treatment in Germany
Imagine a treatment that boosts your own immune response to fight lung cancer with precision, causing virtually no side effects while you maintain your daily routine. Dendritic cell therapy offers this possibility to patients at any cancer stage, showing effectiveness rates of 50-65% across various cancer types. With lung cancer affecting 226,650 new...
Immunotherapy for colon cancer in Germany
Colorectal cancer (CRC) is a significant public health concern in Germany, ranking among the most commonly diagnosed cancers. In 2022, approximately 24,650 women and 29,960 men were newly diagnosed with CRC. The incidence rates are notably higher in individuals over the age of 55, with the majority of cases originating in the colon...
Esophageal Cancer: Treatment in Germany
Esophageal cancer is one of the twenty most widespread cancer types. The disease can develop at any age, but most often it is diagnosed over the age of 60, when treatment options are already somewhat limited by the patient's chronic conditions. Patients who undergo treatment in Germany have a chance to significantly increase...
Immunotherapy treatment for leukemia in Germany
In recent years, doctors in developed countries have increasingly used immunotherapy treatment for leukemia. Healthcare professionals in Germany use innovative drugs that help cope with even refractory and relapsing forms of leukemia. Immunotherapy is mainly used for acute lymphocytic leukemia.
